HUP0101428A2 - Ciszteinproteázgátlót tartalmazó gyógyszerkészítmény agyszöveti károsodás megelőzésére és kezelésére - Google Patents
Ciszteinproteázgátlót tartalmazó gyógyszerkészítmény agyszöveti károsodás megelőzésére és kezelésére Download PDFInfo
- Publication number
- HUP0101428A2 HUP0101428A2 HU0101428A HUP0101428A HUP0101428A2 HU P0101428 A2 HUP0101428 A2 HU P0101428A2 HU 0101428 A HU0101428 A HU 0101428A HU P0101428 A HUP0101428 A HU P0101428A HU P0101428 A2 HUP0101428 A2 HU P0101428A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- pharmaceutical composition
- general formula
- composition according
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7228098 | 1998-03-20 | ||
| PCT/JP1999/001335 WO1999048522A1 (en) | 1998-03-20 | 1999-03-17 | Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0101428A2 true HUP0101428A2 (hu) | 2001-09-28 |
Family
ID=13484725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101428A HUP0101428A2 (hu) | 1998-03-20 | 1999-03-17 | Ciszteinproteázgátlót tartalmazó gyógyszerkészítmény agyszöveti károsodás megelőzésére és kezelésére |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6342531B1 (enExample) |
| EP (1) | EP1064021B1 (enExample) |
| JP (1) | JP2002507579A (enExample) |
| KR (1) | KR20010041967A (enExample) |
| CN (1) | CN1301173A (enExample) |
| AR (1) | AR018784A1 (enExample) |
| AT (1) | ATE275420T1 (enExample) |
| AU (1) | AU2852699A (enExample) |
| BR (1) | BR9908948A (enExample) |
| CA (1) | CA2324566A1 (enExample) |
| DE (1) | DE69919995T2 (enExample) |
| ES (1) | ES2224613T3 (enExample) |
| HU (1) | HUP0101428A2 (enExample) |
| ID (1) | ID27507A (enExample) |
| MX (1) | MXPA00009188A (enExample) |
| MY (1) | MY133063A (enExample) |
| NO (1) | NO20004679L (enExample) |
| PL (1) | PL342970A1 (enExample) |
| WO (1) | WO1999048522A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7766300A (en) * | 1999-10-07 | 2001-05-10 | Novaneuron Inc. | Gene necessary for striatal function, uses thereof, and compounds for modulatingsame |
| JPWO2002034252A1 (ja) | 2000-10-26 | 2004-03-04 | 千寿製薬株式会社 | ジペプチジルアルデヒド誘導体含有医薬組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992011850A2 (en) | 1990-12-28 | 1992-07-23 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| ATE239698T1 (de) | 1995-10-25 | 2003-05-15 | Senju Pharma Co | Angiogenese hemmer |
-
1999
- 1999-03-17 MY MYPI99000998A patent/MY133063A/en unknown
- 1999-03-17 PL PL99342970A patent/PL342970A1/xx not_active Application Discontinuation
- 1999-03-17 WO PCT/JP1999/001335 patent/WO1999048522A1/en not_active Ceased
- 1999-03-17 HU HU0101428A patent/HUP0101428A2/hu unknown
- 1999-03-17 JP JP2000537569A patent/JP2002507579A/ja not_active Ceased
- 1999-03-17 EP EP99909212A patent/EP1064021B1/en not_active Expired - Lifetime
- 1999-03-17 MX MXPA00009188A patent/MXPA00009188A/es unknown
- 1999-03-17 US US09/646,529 patent/US6342531B1/en not_active Expired - Fee Related
- 1999-03-17 CA CA002324566A patent/CA2324566A1/en not_active Abandoned
- 1999-03-17 AT AT99909212T patent/ATE275420T1/de not_active IP Right Cessation
- 1999-03-17 DE DE69919995T patent/DE69919995T2/de not_active Expired - Lifetime
- 1999-03-17 BR BR9908948-3A patent/BR9908948A/pt not_active Application Discontinuation
- 1999-03-17 ID IDW20002104A patent/ID27507A/id unknown
- 1999-03-17 ES ES99909212T patent/ES2224613T3/es not_active Expired - Lifetime
- 1999-03-17 KR KR1020007010291A patent/KR20010041967A/ko not_active Withdrawn
- 1999-03-17 AU AU28526/99A patent/AU2852699A/en not_active Abandoned
- 1999-03-17 CN CN99806167A patent/CN1301173A/zh active Pending
- 1999-03-19 AR ARP990101215A patent/AR018784A1/es unknown
-
2000
- 2000-09-19 NO NO20004679A patent/NO20004679L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL342970A1 (en) | 2001-07-16 |
| MXPA00009188A (es) | 2002-04-24 |
| EP1064021B1 (en) | 2004-09-08 |
| ES2224613T3 (es) | 2005-03-01 |
| ID27507A (id) | 2001-04-12 |
| KR20010041967A (ko) | 2001-05-25 |
| NO20004679D0 (no) | 2000-09-19 |
| ATE275420T1 (de) | 2004-09-15 |
| DE69919995D1 (de) | 2004-10-14 |
| DE69919995T2 (de) | 2005-09-22 |
| US6342531B1 (en) | 2002-01-29 |
| AR018784A1 (es) | 2001-12-12 |
| BR9908948A (pt) | 2000-11-21 |
| MY133063A (en) | 2007-10-31 |
| WO1999048522A1 (en) | 1999-09-30 |
| JP2002507579A (ja) | 2002-03-12 |
| NO20004679L (no) | 2000-10-26 |
| CA2324566A1 (en) | 1999-09-30 |
| EP1064021A1 (en) | 2001-01-03 |
| CN1301173A (zh) | 2001-06-27 |
| AU2852699A (en) | 1999-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100849999B1 (ko) | 두통, 편두통, 구역질 및 구토를 위한 약학적 조성물 | |
| JP2020169187A (ja) | 僧帽弁疾患による無症候性心不全の患者の心臓サイズの減少及び／又は臨床的症候の発生の遅延のためのピモベンダンの使用 | |
| AU2011334592C1 (en) | Methods of treating eye diseases associated with inflammation and vascular proliferation | |
| US7825156B2 (en) | Method of treating bipolar depression with a benzamide derivative | |
| CA1228818A (en) | Treatment of seizure disorders and pharmaceutical compositions useful therein | |
| HUP0101733A2 (hu) | Szulfonil dipeptideket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| KR20230116002A (ko) | 항혈전제로서 시클로스포린 유사체의 용도 | |
| JP5663014B2 (ja) | 虚血および／または再灌流関連疾患の処置に使用されるジヒドロ−１，３，５−トリアジンのアミノ誘導体 | |
| AU2012308243A1 (en) | Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury | |
| EP2538935B1 (en) | Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine | |
| ES2237625T3 (es) | Uso de un derivado de hidantoina en una composicion farmaceutica contra la hipoalbuminemia. | |
| EP1064021B1 (en) | Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. | |
| KR20190087572A (ko) | 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도 | |
| JPH01211522A (ja) | 梗塞および急性脳虚血の予防薬 | |
| WO2009135432A1 (zh) | 丹酚酸b的抗血栓应用 | |
| UA125394C2 (uk) | Нове застосування n,n-біс-2-меркаптоетилізофталаміду | |
| KR20050031499A (ko) | 뇌허혈성 질환의 예방 및 치료용 조성물 | |
| US20100249238A1 (en) | Pharmaceutical compositions comprising semicarbazones and thiosemicarbazones and method for treating inflammatory, painful and febrile conditions and preventing signs and symptoms of inflammation | |
| US20230301972A1 (en) | Anti-fibrotic composition and related methods | |
| CA2213507A1 (en) | Pharmaceutical composition for treating transient ischemic attack | |
| HK40015213A (en) | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder | |
| KR20010006136A (ko) | 궤양성 대장염 및/또는 크론병 예방 및 치료제 |